Microsoft creates 'Plasma Bot' to help recruit donors in effort to cure COVID-19

Antibodies in plasma from healed coronavirus patients could aid in others' recovery.

Corinne Reichert Senior Editor
Corinne Reichert (she/her) grew up in Sydney, Australia and moved to California in 2019. She holds degrees in law and communications, and currently writes news, analysis and features for CNET across the topics of electric vehicles, broadband networks, mobile devices, big tech, artificial intelligence, home technology and entertainment. In her spare time, she watches soccer games and F1 races, and goes to Disneyland as often as possible.
Expertise News, mobile, broadband, 5G, home tech, streaming services, entertainment, AI, policy, business, politics Credentials
  • I've been covering technology and mobile for 12 years, first as a telecommunications reporter and assistant editor at ZDNet in Australia, then as CNET's West Coast head of breaking news, and now in the Thought Leadership team.
Corinne Reichert
Statue of Liberty wearing a face mask to protect from Coronavirus
James Martin/CNET

Microsoft has built a so-called Plasma Bot as part of a larger initiative to seek plasma donations from recovered coronavirus patients called the CoVIg-19 Plasma Alliance. The alliance is asking people whose doctors have confirmed they're fully recovered from COVID-19 and are no longer contagious to donate their plasma at the nearest center. The antibodies in the plasma will be used to look into developing therapies for a possible cure, as reported earlier Saturday by CNBC.

Also on the alliance are Biotest, BPL, LFB and Octapharma, while the Bill & Melinda Gates Foundation is an advisory partner. They're working on collecting plasma, developing clinical trials and eventually manufacturing a product.

"The sooner recovered COVID-19 patients donate convalescent plasma, the sooner the Alliance may be able to start manufacturing a potential therapy and begin clinical trials," the CoVIg-19 Plasma Alliance website says. "These trials will determine if this therapy could treat patients who are at risk for serious complications from COVID-19."

Uplifting scenes of coronavirus solidarity around the world

See all photos
Watch this: Contact tracing explained: How apps can slow the coronavirus